Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Anheuser-Busch Inbev SA (BUD) vs DuPont de Nemours Inc (DD) Price & Performance

Anheuser-Busch Inbev SATrade
DuPont de Nemours IncTrade

Price performance (Past 24H)

Key statistics

Anheuser-Busch Inbev SA vs DuPont de Nemours Inc — how do they compare? Anheuser-Busch Inbev SA trades at $79.37 (market cap $153.27B), while DuPont de Nemours Inc trades at $134.41 (market cap $17.91B). The key difference: Anheuser-Busch Inbev SA is far larger — about 8.6× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.81%). Which is the better fit depends on your goals.

BUDDD
Market Cap
$153.27B$17.91B
Sector
Consumer StaplesBasic Materials
52-Week High
$85.09$154.59
52-Week Low
$57.10$87.72
Enterprise Value
$214.46B$20.37B
Dividend Yield
1.7%1.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Anheuser-Busch Inbev SA

BUD trades at $79.33, down 0.35% with bearish technical signals. The company demonstrates solid fundamentals with consistent earnings beats, 11.9% net margin, and improving cash flow. Recent dividend payment of $1.17 and positive analyst sentiment with 57.8% buy ratings support the investment case. Premiumization strategy and digital expansion drive growth amid changing consumer preferences.

Outlook remains positive with $90.08 consensus price target offering 13.5% upside. Key risks include alcohol moderation trends and competitive pressures. Strong balance sheet with declining debt-to-asset ratio to 33.9% provides financial stability. Revenue growth expected to accelerate to $61B in 2026 with expanding margins.

DuPont de Nemours Inc

DuPont (DD) trades at $132.66, down 1.5% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong gross margins (35.01%) but negative net income margin (-0.42%) and ROE (-0.16%). Analyst consensus remains bullish with a $227.20 price target (71% upside), though the company faces legal challenges and persistent net cash outflows. Recent developments include water technology upgrades and a 3:1 reverse stock split effective June 2026.

While analyst optimism and valuation discount to price target suggest potential upside, investors face significant risks including ongoing litigation over 'forever chemicals,' weak profitability trends, and concerning cash flow patterns. The stock's current technical weakness near support levels requires careful monitoring of Q2 2026 earnings results due July 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Anheuser-Busch Inbev SA

Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. After the SABMiller acquisition, the company's portfolio now contains five of the top 10 beer brands by sales and 18 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and U.S.-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 acquired SABMiller.

Read more on BUD

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD